The Impact of COVID-19 is included in Inherited Retinal Disease Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Inherited Retinal Disease Trends and Forecast
The future of the global inherited retinal disease (IRD) market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets. The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are governmentÄX%$%Xs increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Inherited Retinal Disease by Segment
The study includes a forecast for the global inherited retinal disease by type, disease type, end use, distribution channel, and region.
Inherited Retinal Disease Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Diagnosis
• Therapy
Inherited Retinal Disease Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:
• Retinitis Pigmentosa
• StargardtÄX%$%XS Disease
• Achromatopsia
• Cone-Rod Dystrophy
• Choroideremia
• Leber Congenital Amaurosis
• Macular Edema
• Others
Inherited Retinal Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Home Healthcare
• Others
Inherited Retinal Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Retail Sales
• Direct Tender
Inherited Retinal Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Inherited Retinal Disease Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inherited retinal disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inherited retinal disease companies profiled in this report include-
• Spark Therapeutics
• Novartis
• Okuvision
• Nidek
• Invitae Corporation
• Zeiss
• Optos
Inherited Retinal Disease Market Insights
Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.
Within this market, hospital will remain the largest segment due to the presence of resources and expertise to provide a wide range of services for patients with inherited retinal diseases, including diagnosis, treatment, and rehabilitation.
North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.
Features of the Global Inherited Retinal Disease Market
Market Size Estimates: Inherited retinal disease market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Inherited retinal disease market size by various segments, such as by type, disease type, end use, distribution channel, and region in terms of ($B).
Regional Analysis: Inherited retinal disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, disease types, end uses, distribution channels, and regions for the inherited retinal disease market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inherited retinal disease market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the inherited retinal disease market size?
Answer: The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030.
Q.2 What is the growth forecast for inherited retinal disease market?
Answer: The global inherited retinal disease market is expected to grow with a CAGR of 7.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the inherited retinal disease market?
Answer: The major drivers for this market are governmentÄX%$%Xs increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.
Q4. What are the major segments for inherited retinal disease market?
Answer: The future of the inherited retinal disease market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets.
Q5. Who are the key inherited retinal disease market companies?
Answer: Some of the key inherited retinal disease companies are as follows:
• Spark Therapeutics
• Novartis
• Okuvision
• Nidek
• Invitae Corporation
• Zeiss
• Optos
Q6. Which inherited retinal disease market segment will be the largest in future?
Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.
Q7. In inherited retinal disease market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the inherited retinal disease market by type (diagnosis and therapy), disease type (retinitis pigmentosa, stargardtÄX%$%Xs disease, achromatopsia, cone-rod dystrophy, choroideremia, leber congenital amaurosis, macular edema, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others), distribution channel (retail sales and direct tender), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Inherited Retinal Disease Market, Inherited Retinal Disease Market Size, Inherited Retinal Disease Market Growth, Inherited Retinal Disease Market Analysis, Inherited Retinal Disease Market Report, Inherited Retinal Disease Market Share, Inherited Retinal Disease Market Trends, Inherited Retinal Disease Market Forecast, Inherited Retinal Disease Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Inherited Retinal Disease Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Inherited Retinal Disease Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Inherited Retinal Disease Market by Type
3.3.1: Diagnosis
3.3.2: Therapy
3.4: Global Inherited Retinal Disease Market by Disease Type
3.4.1: Retinitis Pigmentosa
3.4.2: StargardtÄX%$%Xs Disease
3.4.3: Achromatopsia
3.4.4: Cone-Rod Dystrophy
3.4.5: Choroideremia
3.4.6: Leber Congenital Amaurosis
3.4.7: Macular Edema
3.4.8: Others
3.5: Global Inherited Retinal Disease Market by End Use
3.5.1: Hospitals
3.5.2: Specialty Clinics
3.5.3: Ambulatory Surgical Centers
3.5.4: Home Healthcare
3.5.5: Others
3.6: Global Inherited Retinal Disease Market by Distribution Channel
3.6.1: Retail Sales
3.6.2: Direct Tender
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Inherited Retinal Disease Market by Region
4.2: North American Inherited Retinal Disease Market
4.2.2: North American Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
4.3: European Inherited Retinal Disease Market
4.3.1: European Inherited Retinal Disease Market by Type: Diagnosis and Therapy
4.3.2: European Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
4.4: APAC Inherited Retinal Disease Market
4.4.1: APAC Inherited Retinal Disease Market by Type: Diagnosis and Therapy
4.4.2: APAC Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
4.5: ROW Inherited Retinal Disease Market
4.5.1: ROW Inherited Retinal Disease Market by Type: Diagnosis and Therapy
4.5.2: ROW Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Inherited Retinal Disease Market by Type
6.1.2: Growth Opportunities for the Global Inherited Retinal Disease Market by Disease Type
6.1.3: Growth Opportunities for the Global Inherited Retinal Disease Market by End Use
6.1.4: Growth Opportunities for the Global Inherited Retinal Disease Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Inherited Retinal Disease Market by Region
6.2: Emerging Trends in the Global Inherited Retinal Disease Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Inherited Retinal Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inherited Retinal Disease Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Spark Therapeutics
7.2: Novartis
7.3: Okuvision
7.4: Nidek
7.5: Invitae Corporation
7.6: Zeiss
7.7: Optos
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Inherited Retinal Disease Market Report.